High-Risk Patients

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 15 January, 2026 0

Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 15 January, 2026 0

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Dr. Omar Tupayachi - 14 January, 2026 0

Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: High-Risk Patients

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

ESC 2023 | Extended Monotherapy with Clopidogrel vs. DAPT in High-Risk...

Últimas Noticias

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Is it safe to use negative chronotropic drugs early after TAVI?

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Noticias Institucionales

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Accesos